nodes	percent_of_prediction	percent_of_DWPC	metapath
Pantoprazole—ABCG2—Vandetanib—thyroid cancer	0.177	0.287	CbGbCtD
Pantoprazole—ABCG2—Sorafenib—thyroid cancer	0.107	0.173	CbGbCtD
Pantoprazole—ABCG2—Doxorubicin—thyroid cancer	0.0647	0.105	CbGbCtD
Pantoprazole—CYP2C19—Sorafenib—thyroid cancer	0.0477	0.0773	CbGbCtD
Pantoprazole—CYP1A2—Sorafenib—thyroid cancer	0.044	0.0713	CbGbCtD
Pantoprazole—CYP2C9—Sorafenib—thyroid cancer	0.0396	0.0643	CbGbCtD
Pantoprazole—ABCB1—Sorafenib—thyroid cancer	0.0385	0.0624	CbGbCtD
Pantoprazole—CYP3A4—Vandetanib—thyroid cancer	0.0382	0.062	CbGbCtD
Pantoprazole—ABCB1—Doxorubicin—thyroid cancer	0.0233	0.0378	CbGbCtD
Pantoprazole—CYP3A4—Sorafenib—thyroid cancer	0.0231	0.0374	CbGbCtD
Pantoprazole—ATP4A—larynx—thyroid cancer	0.0209	0.623	CbGeAlD
Pantoprazole—CYP3A4—Doxorubicin—thyroid cancer	0.014	0.0227	CbGbCtD
Pantoprazole—ATP4A—neck—thyroid cancer	0.00554	0.165	CbGeAlD
Pantoprazole—ATP4A—head—thyroid cancer	0.00234	0.0698	CbGeAlD
Pantoprazole—ABCG2—saliva-secreting gland—thyroid cancer	0.00128	0.0382	CbGeAlD
Pantoprazole—ABCG2—thyroid gland—thyroid cancer	0.000782	0.0233	CbGeAlD
Pantoprazole—CYP1A2—thyroid gland—thyroid cancer	0.000752	0.0224	CbGeAlD
Pantoprazole—ABCB1—trachea—thyroid cancer	0.000487	0.0145	CbGeAlD
Pantoprazole—ABCG2—lymph node—thyroid cancer	0.000486	0.0145	CbGeAlD
Pantoprazole—ABCB1—thyroid gland—thyroid cancer	0.000385	0.0115	CbGeAlD
Pantoprazole—ABCB1—head—thyroid cancer	0.000342	0.0102	CbGeAlD
Pantoprazole—Dizziness—Sorafenib—thyroid cancer	0.000241	0.000689	CcSEcCtD
Pantoprazole—Mood swings—Doxorubicin—thyroid cancer	0.00024	0.000687	CcSEcCtD
Pantoprazole—ABCB1—lymph node—thyroid cancer	0.000239	0.00714	CbGeAlD
Pantoprazole—Abdominal distension—Epirubicin—thyroid cancer	0.000238	0.000682	CcSEcCtD
Pantoprazole—Blood creatinine increased—Doxorubicin—thyroid cancer	0.000237	0.000679	CcSEcCtD
Pantoprazole—Influenza—Epirubicin—thyroid cancer	0.000237	0.000677	CcSEcCtD
Pantoprazole—Asthma—Epirubicin—thyroid cancer	0.000237	0.000677	CcSEcCtD
Pantoprazole—Dysphagia—Epirubicin—thyroid cancer	0.000237	0.000677	CcSEcCtD
Pantoprazole—Dehydration—Doxorubicin—thyroid cancer	0.000236	0.000674	CcSEcCtD
Pantoprazole—Eosinophilia—Epirubicin—thyroid cancer	0.000234	0.00067	CcSEcCtD
Pantoprazole—Liver function test abnormal—Doxorubicin—thyroid cancer	0.000234	0.000669	CcSEcCtD
Pantoprazole—Dry skin—Doxorubicin—thyroid cancer	0.000232	0.000664	CcSEcCtD
Pantoprazole—Pancreatitis—Epirubicin—thyroid cancer	0.000232	0.000664	CcSEcCtD
Pantoprazole—Vomiting—Sorafenib—thyroid cancer	0.000232	0.000662	CcSEcCtD
Pantoprazole—Abdominal pain upper—Doxorubicin—thyroid cancer	0.000231	0.000662	CcSEcCtD
Pantoprazole—Angina pectoris—Epirubicin—thyroid cancer	0.000231	0.00066	CcSEcCtD
Pantoprazole—Rash—Sorafenib—thyroid cancer	0.00023	0.000657	CcSEcCtD
Pantoprazole—Dermatitis—Sorafenib—thyroid cancer	0.000229	0.000656	CcSEcCtD
Pantoprazole—Breast disorder—Doxorubicin—thyroid cancer	0.000229	0.000655	CcSEcCtD
Pantoprazole—Toxic epidermal necrolysis—Doxorubicin—thyroid cancer	0.000228	0.000653	CcSEcCtD
Pantoprazole—Aspartate aminotransferase increased—Doxorubicin—thyroid cancer	0.000228	0.000653	CcSEcCtD
Pantoprazole—Headache—Sorafenib—thyroid cancer	0.000228	0.000653	CcSEcCtD
Pantoprazole—Bronchitis—Epirubicin—thyroid cancer	0.000228	0.000651	CcSEcCtD
Pantoprazole—Nasopharyngitis—Doxorubicin—thyroid cancer	0.000227	0.000648	CcSEcCtD
Pantoprazole—Pancytopenia—Epirubicin—thyroid cancer	0.000225	0.000643	CcSEcCtD
Pantoprazole—Gastritis—Doxorubicin—thyroid cancer	0.000224	0.000641	CcSEcCtD
Pantoprazole—Alanine aminotransferase increased—Doxorubicin—thyroid cancer	0.000223	0.000639	CcSEcCtD
Pantoprazole—Dysuria—Epirubicin—thyroid cancer	0.000221	0.000633	CcSEcCtD
Pantoprazole—Abdominal distension—Doxorubicin—thyroid cancer	0.00022	0.000631	CcSEcCtD
Pantoprazole—Upper respiratory tract infection—Epirubicin—thyroid cancer	0.00022	0.000629	CcSEcCtD
Pantoprazole—Asthma—Doxorubicin—thyroid cancer	0.000219	0.000626	CcSEcCtD
Pantoprazole—Influenza—Doxorubicin—thyroid cancer	0.000219	0.000626	CcSEcCtD
Pantoprazole—Dysphagia—Doxorubicin—thyroid cancer	0.000219	0.000626	CcSEcCtD
Pantoprazole—Pollakiuria—Epirubicin—thyroid cancer	0.000219	0.000625	CcSEcCtD
Pantoprazole—Eosinophilia—Doxorubicin—thyroid cancer	0.000217	0.00062	CcSEcCtD
Pantoprazole—Nausea—Sorafenib—thyroid cancer	0.000216	0.000619	CcSEcCtD
Pantoprazole—Photosensitivity reaction—Epirubicin—thyroid cancer	0.000216	0.000618	CcSEcCtD
Pantoprazole—Weight increased—Epirubicin—thyroid cancer	0.000215	0.000616	CcSEcCtD
Pantoprazole—Pancreatitis—Doxorubicin—thyroid cancer	0.000215	0.000614	CcSEcCtD
Pantoprazole—Weight decreased—Epirubicin—thyroid cancer	0.000214	0.000613	CcSEcCtD
Pantoprazole—Hyperglycaemia—Epirubicin—thyroid cancer	0.000213	0.000611	CcSEcCtD
Pantoprazole—Angina pectoris—Doxorubicin—thyroid cancer	0.000213	0.00061	CcSEcCtD
Pantoprazole—Pneumonia—Epirubicin—thyroid cancer	0.000212	0.000607	CcSEcCtD
Pantoprazole—Infestation NOS—Epirubicin—thyroid cancer	0.000211	0.000604	CcSEcCtD
Pantoprazole—Infestation—Epirubicin—thyroid cancer	0.000211	0.000604	CcSEcCtD
Pantoprazole—Bronchitis—Doxorubicin—thyroid cancer	0.000211	0.000602	CcSEcCtD
Pantoprazole—Stevens-Johnson syndrome—Epirubicin—thyroid cancer	0.000209	0.000598	CcSEcCtD
Pantoprazole—Pancytopenia—Doxorubicin—thyroid cancer	0.000208	0.000595	CcSEcCtD
Pantoprazole—Neuropathy peripheral—Epirubicin—thyroid cancer	0.000207	0.000592	CcSEcCtD
Pantoprazole—Stomatitis—Epirubicin—thyroid cancer	0.000206	0.000588	CcSEcCtD
Pantoprazole—Jaundice—Epirubicin—thyroid cancer	0.000206	0.000588	CcSEcCtD
Pantoprazole—Conjunctivitis—Epirubicin—thyroid cancer	0.000205	0.000587	CcSEcCtD
Pantoprazole—Urinary tract infection—Epirubicin—thyroid cancer	0.000205	0.000587	CcSEcCtD
Pantoprazole—Dysuria—Doxorubicin—thyroid cancer	0.000205	0.000586	CcSEcCtD
Pantoprazole—Upper respiratory tract infection—Doxorubicin—thyroid cancer	0.000203	0.000582	CcSEcCtD
Pantoprazole—Sweating—Epirubicin—thyroid cancer	0.000202	0.000579	CcSEcCtD
Pantoprazole—Pollakiuria—Doxorubicin—thyroid cancer	0.000202	0.000579	CcSEcCtD
Pantoprazole—Haematuria—Epirubicin—thyroid cancer	0.000201	0.000576	CcSEcCtD
Pantoprazole—Photosensitivity reaction—Doxorubicin—thyroid cancer	0.0002	0.000572	CcSEcCtD
Pantoprazole—Hepatobiliary disease—Epirubicin—thyroid cancer	0.0002	0.000571	CcSEcCtD
Pantoprazole—Weight increased—Doxorubicin—thyroid cancer	0.000199	0.00057	CcSEcCtD
Pantoprazole—Epistaxis—Epirubicin—thyroid cancer	0.000199	0.000569	CcSEcCtD
Pantoprazole—Weight decreased—Doxorubicin—thyroid cancer	0.000198	0.000567	CcSEcCtD
Pantoprazole—Sinusitis—Epirubicin—thyroid cancer	0.000198	0.000566	CcSEcCtD
Pantoprazole—Hyperglycaemia—Doxorubicin—thyroid cancer	0.000198	0.000565	CcSEcCtD
Pantoprazole—Agranulocytosis—Epirubicin—thyroid cancer	0.000197	0.000563	CcSEcCtD
Pantoprazole—Pneumonia—Doxorubicin—thyroid cancer	0.000196	0.000562	CcSEcCtD
Pantoprazole—Infestation NOS—Doxorubicin—thyroid cancer	0.000195	0.000559	CcSEcCtD
Pantoprazole—Infestation—Doxorubicin—thyroid cancer	0.000195	0.000559	CcSEcCtD
Pantoprazole—Stevens-Johnson syndrome—Doxorubicin—thyroid cancer	0.000194	0.000554	CcSEcCtD
Pantoprazole—Neuropathy peripheral—Doxorubicin—thyroid cancer	0.000191	0.000548	CcSEcCtD
Pantoprazole—Haemoglobin—Epirubicin—thyroid cancer	0.00019	0.000545	CcSEcCtD
Pantoprazole—Jaundice—Doxorubicin—thyroid cancer	0.00019	0.000544	CcSEcCtD
Pantoprazole—Stomatitis—Doxorubicin—thyroid cancer	0.00019	0.000544	CcSEcCtD
Pantoprazole—Rhinitis—Epirubicin—thyroid cancer	0.00019	0.000543	CcSEcCtD
Pantoprazole—Conjunctivitis—Doxorubicin—thyroid cancer	0.00019	0.000543	CcSEcCtD
Pantoprazole—Urinary tract infection—Doxorubicin—thyroid cancer	0.00019	0.000543	CcSEcCtD
Pantoprazole—Haemorrhage—Epirubicin—thyroid cancer	0.000189	0.000542	CcSEcCtD
Pantoprazole—Hepatitis—Epirubicin—thyroid cancer	0.000189	0.000542	CcSEcCtD
Pantoprazole—Hypoaesthesia—Epirubicin—thyroid cancer	0.000188	0.000539	CcSEcCtD
Pantoprazole—Pharyngitis—Epirubicin—thyroid cancer	0.000188	0.000538	CcSEcCtD
Pantoprazole—Sweating—Doxorubicin—thyroid cancer	0.000187	0.000535	CcSEcCtD
Pantoprazole—Urinary tract disorder—Epirubicin—thyroid cancer	0.000187	0.000535	CcSEcCtD
Pantoprazole—Oedema peripheral—Epirubicin—thyroid cancer	0.000187	0.000534	CcSEcCtD
Pantoprazole—Haematuria—Doxorubicin—thyroid cancer	0.000186	0.000533	CcSEcCtD
Pantoprazole—Connective tissue disorder—Epirubicin—thyroid cancer	0.000186	0.000533	CcSEcCtD
Pantoprazole—Urethral disorder—Epirubicin—thyroid cancer	0.000186	0.000531	CcSEcCtD
Pantoprazole—Hepatobiliary disease—Doxorubicin—thyroid cancer	0.000185	0.000528	CcSEcCtD
Pantoprazole—Epistaxis—Doxorubicin—thyroid cancer	0.000184	0.000527	CcSEcCtD
Pantoprazole—Sinusitis—Doxorubicin—thyroid cancer	0.000183	0.000524	CcSEcCtD
Pantoprazole—Visual impairment—Epirubicin—thyroid cancer	0.000183	0.000522	CcSEcCtD
Pantoprazole—Agranulocytosis—Doxorubicin—thyroid cancer	0.000182	0.000521	CcSEcCtD
Pantoprazole—Erythema multiforme—Epirubicin—thyroid cancer	0.000179	0.000512	CcSEcCtD
Pantoprazole—Eye disorder—Epirubicin—thyroid cancer	0.000177	0.000506	CcSEcCtD
Pantoprazole—Tinnitus—Epirubicin—thyroid cancer	0.000177	0.000505	CcSEcCtD
Pantoprazole—Haemoglobin—Doxorubicin—thyroid cancer	0.000176	0.000504	CcSEcCtD
Pantoprazole—Flushing—Epirubicin—thyroid cancer	0.000176	0.000503	CcSEcCtD
Pantoprazole—Rhinitis—Doxorubicin—thyroid cancer	0.000176	0.000503	CcSEcCtD
Pantoprazole—Haemorrhage—Doxorubicin—thyroid cancer	0.000175	0.000501	CcSEcCtD
Pantoprazole—Hepatitis—Doxorubicin—thyroid cancer	0.000175	0.000501	CcSEcCtD
Pantoprazole—Hypoaesthesia—Doxorubicin—thyroid cancer	0.000174	0.000499	CcSEcCtD
Pantoprazole—Pharyngitis—Doxorubicin—thyroid cancer	0.000174	0.000498	CcSEcCtD
Pantoprazole—Urinary tract disorder—Doxorubicin—thyroid cancer	0.000173	0.000495	CcSEcCtD
Pantoprazole—Oedema peripheral—Doxorubicin—thyroid cancer	0.000173	0.000494	CcSEcCtD
Pantoprazole—Connective tissue disorder—Doxorubicin—thyroid cancer	0.000172	0.000493	CcSEcCtD
Pantoprazole—Urethral disorder—Doxorubicin—thyroid cancer	0.000172	0.000492	CcSEcCtD
Pantoprazole—Immune system disorder—Epirubicin—thyroid cancer	0.000171	0.000489	CcSEcCtD
Pantoprazole—Chills—Epirubicin—thyroid cancer	0.00017	0.000486	CcSEcCtD
Pantoprazole—Arrhythmia—Epirubicin—thyroid cancer	0.000169	0.000484	CcSEcCtD
Pantoprazole—Visual impairment—Doxorubicin—thyroid cancer	0.000169	0.000483	CcSEcCtD
Pantoprazole—Alopecia—Epirubicin—thyroid cancer	0.000167	0.000479	CcSEcCtD
Pantoprazole—Mental disorder—Epirubicin—thyroid cancer	0.000166	0.000475	CcSEcCtD
Pantoprazole—Erythema multiforme—Doxorubicin—thyroid cancer	0.000166	0.000474	CcSEcCtD
Pantoprazole—Malnutrition—Epirubicin—thyroid cancer	0.000165	0.000472	CcSEcCtD
Pantoprazole—Eye disorder—Doxorubicin—thyroid cancer	0.000164	0.000469	CcSEcCtD
Pantoprazole—Tinnitus—Doxorubicin—thyroid cancer	0.000163	0.000468	CcSEcCtD
Pantoprazole—Flushing—Doxorubicin—thyroid cancer	0.000163	0.000465	CcSEcCtD
Pantoprazole—Flatulence—Epirubicin—thyroid cancer	0.000162	0.000465	CcSEcCtD
Pantoprazole—Tension—Epirubicin—thyroid cancer	0.000162	0.000463	CcSEcCtD
Pantoprazole—Dysgeusia—Epirubicin—thyroid cancer	0.000161	0.000462	CcSEcCtD
Pantoprazole—Nervousness—Epirubicin—thyroid cancer	0.00016	0.000458	CcSEcCtD
Pantoprazole—Back pain—Epirubicin—thyroid cancer	0.000159	0.000456	CcSEcCtD
Pantoprazole—Muscle spasms—Epirubicin—thyroid cancer	0.000159	0.000454	CcSEcCtD
Pantoprazole—Immune system disorder—Doxorubicin—thyroid cancer	0.000158	0.000453	CcSEcCtD
Pantoprazole—Chills—Doxorubicin—thyroid cancer	0.000157	0.00045	CcSEcCtD
Pantoprazole—Arrhythmia—Doxorubicin—thyroid cancer	0.000157	0.000448	CcSEcCtD
Pantoprazole—Vision blurred—Epirubicin—thyroid cancer	0.000155	0.000445	CcSEcCtD
Pantoprazole—Alopecia—Doxorubicin—thyroid cancer	0.000155	0.000443	CcSEcCtD
Pantoprazole—Mental disorder—Doxorubicin—thyroid cancer	0.000154	0.000439	CcSEcCtD
Pantoprazole—Ill-defined disorder—Epirubicin—thyroid cancer	0.000153	0.000438	CcSEcCtD
Pantoprazole—Malnutrition—Doxorubicin—thyroid cancer	0.000153	0.000437	CcSEcCtD
Pantoprazole—Anaemia—Epirubicin—thyroid cancer	0.000152	0.000436	CcSEcCtD
Pantoprazole—Agitation—Epirubicin—thyroid cancer	0.000152	0.000434	CcSEcCtD
Pantoprazole—Flatulence—Doxorubicin—thyroid cancer	0.00015	0.00043	CcSEcCtD
Pantoprazole—Tension—Doxorubicin—thyroid cancer	0.00015	0.000428	CcSEcCtD
Pantoprazole—Dysgeusia—Doxorubicin—thyroid cancer	0.000149	0.000427	CcSEcCtD
Pantoprazole—Malaise—Epirubicin—thyroid cancer	0.000149	0.000425	CcSEcCtD
Pantoprazole—Nervousness—Doxorubicin—thyroid cancer	0.000148	0.000424	CcSEcCtD
Pantoprazole—Vertigo—Epirubicin—thyroid cancer	0.000148	0.000424	CcSEcCtD
Pantoprazole—Syncope—Epirubicin—thyroid cancer	0.000148	0.000423	CcSEcCtD
Pantoprazole—Leukopenia—Epirubicin—thyroid cancer	0.000148	0.000422	CcSEcCtD
Pantoprazole—Back pain—Doxorubicin—thyroid cancer	0.000148	0.000422	CcSEcCtD
Pantoprazole—Muscle spasms—Doxorubicin—thyroid cancer	0.000147	0.00042	CcSEcCtD
Pantoprazole—Palpitations—Epirubicin—thyroid cancer	0.000146	0.000417	CcSEcCtD
Pantoprazole—Loss of consciousness—Epirubicin—thyroid cancer	0.000145	0.000415	CcSEcCtD
Pantoprazole—Cough—Epirubicin—thyroid cancer	0.000144	0.000412	CcSEcCtD
Pantoprazole—Vision blurred—Doxorubicin—thyroid cancer	0.000144	0.000411	CcSEcCtD
Pantoprazole—Convulsion—Epirubicin—thyroid cancer	0.000143	0.000409	CcSEcCtD
Pantoprazole—Hypertension—Epirubicin—thyroid cancer	0.000142	0.000407	CcSEcCtD
Pantoprazole—Ill-defined disorder—Doxorubicin—thyroid cancer	0.000142	0.000405	CcSEcCtD
Pantoprazole—Anaemia—Doxorubicin—thyroid cancer	0.000141	0.000403	CcSEcCtD
Pantoprazole—Chest pain—Epirubicin—thyroid cancer	0.00014	0.000402	CcSEcCtD
Pantoprazole—Myalgia—Epirubicin—thyroid cancer	0.00014	0.000402	CcSEcCtD
Pantoprazole—Arthralgia—Epirubicin—thyroid cancer	0.00014	0.000402	CcSEcCtD
Pantoprazole—Agitation—Doxorubicin—thyroid cancer	0.00014	0.000401	CcSEcCtD
Pantoprazole—Anxiety—Epirubicin—thyroid cancer	0.00014	0.0004	CcSEcCtD
Pantoprazole—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.000139	0.000399	CcSEcCtD
Pantoprazole—Discomfort—Epirubicin—thyroid cancer	0.000139	0.000397	CcSEcCtD
Pantoprazole—Malaise—Doxorubicin—thyroid cancer	0.000138	0.000394	CcSEcCtD
Pantoprazole—Dry mouth—Epirubicin—thyroid cancer	0.000137	0.000393	CcSEcCtD
Pantoprazole—Vertigo—Doxorubicin—thyroid cancer	0.000137	0.000392	CcSEcCtD
Pantoprazole—Syncope—Doxorubicin—thyroid cancer	0.000137	0.000391	CcSEcCtD
Pantoprazole—Leukopenia—Doxorubicin—thyroid cancer	0.000137	0.000391	CcSEcCtD
Pantoprazole—Confusional state—Epirubicin—thyroid cancer	0.000136	0.000388	CcSEcCtD
Pantoprazole—Palpitations—Doxorubicin—thyroid cancer	0.000135	0.000386	CcSEcCtD
Pantoprazole—Oedema—Epirubicin—thyroid cancer	0.000135	0.000385	CcSEcCtD
Pantoprazole—Anaphylactic shock—Epirubicin—thyroid cancer	0.000135	0.000385	CcSEcCtD
Pantoprazole—Loss of consciousness—Doxorubicin—thyroid cancer	0.000134	0.000384	CcSEcCtD
Pantoprazole—Infection—Epirubicin—thyroid cancer	0.000134	0.000382	CcSEcCtD
Pantoprazole—Cough—Doxorubicin—thyroid cancer	0.000133	0.000381	CcSEcCtD
Pantoprazole—Shock—Epirubicin—thyroid cancer	0.000132	0.000379	CcSEcCtD
Pantoprazole—Convulsion—Doxorubicin—thyroid cancer	0.000132	0.000378	CcSEcCtD
Pantoprazole—Nervous system disorder—Epirubicin—thyroid cancer	0.000132	0.000378	CcSEcCtD
Pantoprazole—Thrombocytopenia—Epirubicin—thyroid cancer	0.000132	0.000377	CcSEcCtD
Pantoprazole—Hypertension—Doxorubicin—thyroid cancer	0.000132	0.000377	CcSEcCtD
Pantoprazole—Tachycardia—Epirubicin—thyroid cancer	0.000131	0.000376	CcSEcCtD
Pantoprazole—Skin disorder—Epirubicin—thyroid cancer	0.000131	0.000374	CcSEcCtD
Pantoprazole—Hyperhidrosis—Epirubicin—thyroid cancer	0.00013	0.000372	CcSEcCtD
Pantoprazole—Arthralgia—Doxorubicin—thyroid cancer	0.00013	0.000372	CcSEcCtD
Pantoprazole—Chest pain—Doxorubicin—thyroid cancer	0.00013	0.000372	CcSEcCtD
Pantoprazole—Myalgia—Doxorubicin—thyroid cancer	0.00013	0.000372	CcSEcCtD
Pantoprazole—Anxiety—Doxorubicin—thyroid cancer	0.000129	0.00037	CcSEcCtD
Pantoprazole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.000129	0.000369	CcSEcCtD
Pantoprazole—Discomfort—Doxorubicin—thyroid cancer	0.000128	0.000367	CcSEcCtD
Pantoprazole—Anorexia—Epirubicin—thyroid cancer	0.000128	0.000367	CcSEcCtD
Pantoprazole—Dry mouth—Doxorubicin—thyroid cancer	0.000127	0.000363	CcSEcCtD
Pantoprazole—Hypotension—Epirubicin—thyroid cancer	0.000126	0.00036	CcSEcCtD
Pantoprazole—Confusional state—Doxorubicin—thyroid cancer	0.000126	0.000359	CcSEcCtD
Pantoprazole—Oedema—Doxorubicin—thyroid cancer	0.000125	0.000356	CcSEcCtD
Pantoprazole—Anaphylactic shock—Doxorubicin—thyroid cancer	0.000125	0.000356	CcSEcCtD
Pantoprazole—Infection—Doxorubicin—thyroid cancer	0.000124	0.000354	CcSEcCtD
Pantoprazole—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.000123	0.000351	CcSEcCtD
Pantoprazole—Shock—Doxorubicin—thyroid cancer	0.000123	0.00035	CcSEcCtD
Pantoprazole—Nervous system disorder—Doxorubicin—thyroid cancer	0.000122	0.000349	CcSEcCtD
Pantoprazole—Thrombocytopenia—Doxorubicin—thyroid cancer	0.000122	0.000349	CcSEcCtD
Pantoprazole—Insomnia—Epirubicin—thyroid cancer	0.000122	0.000348	CcSEcCtD
Pantoprazole—Tachycardia—Doxorubicin—thyroid cancer	0.000122	0.000348	CcSEcCtD
Pantoprazole—Skin disorder—Doxorubicin—thyroid cancer	0.000121	0.000346	CcSEcCtD
Pantoprazole—Paraesthesia—Epirubicin—thyroid cancer	0.000121	0.000346	CcSEcCtD
Pantoprazole—Hyperhidrosis—Doxorubicin—thyroid cancer	0.00012	0.000344	CcSEcCtD
Pantoprazole—Dyspnoea—Epirubicin—thyroid cancer	0.00012	0.000343	CcSEcCtD
Pantoprazole—Somnolence—Epirubicin—thyroid cancer	0.00012	0.000342	CcSEcCtD
Pantoprazole—Anorexia—Doxorubicin—thyroid cancer	0.000119	0.00034	CcSEcCtD
Pantoprazole—Dyspepsia—Epirubicin—thyroid cancer	0.000118	0.000339	CcSEcCtD
Pantoprazole—Decreased appetite—Epirubicin—thyroid cancer	0.000117	0.000335	CcSEcCtD
Pantoprazole—Hypotension—Doxorubicin—thyroid cancer	0.000116	0.000333	CcSEcCtD
Pantoprazole—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.000116	0.000332	CcSEcCtD
Pantoprazole—Fatigue—Epirubicin—thyroid cancer	0.000116	0.000332	CcSEcCtD
Pantoprazole—Constipation—Epirubicin—thyroid cancer	0.000115	0.000329	CcSEcCtD
Pantoprazole—Pain—Epirubicin—thyroid cancer	0.000115	0.000329	CcSEcCtD
Pantoprazole—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000113	0.000325	CcSEcCtD
Pantoprazole—Insomnia—Doxorubicin—thyroid cancer	0.000113	0.000322	CcSEcCtD
Pantoprazole—Paraesthesia—Doxorubicin—thyroid cancer	0.000112	0.00032	CcSEcCtD
Pantoprazole—Dyspnoea—Doxorubicin—thyroid cancer	0.000111	0.000318	CcSEcCtD
Pantoprazole—Feeling abnormal—Epirubicin—thyroid cancer	0.000111	0.000317	CcSEcCtD
Pantoprazole—Somnolence—Doxorubicin—thyroid cancer	0.000111	0.000317	CcSEcCtD
Pantoprazole—Gastrointestinal pain—Epirubicin—thyroid cancer	0.00011	0.000315	CcSEcCtD
Pantoprazole—Dyspepsia—Doxorubicin—thyroid cancer	0.00011	0.000314	CcSEcCtD
Pantoprazole—Decreased appetite—Doxorubicin—thyroid cancer	0.000108	0.00031	CcSEcCtD
Pantoprazole—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000107	0.000308	CcSEcCtD
Pantoprazole—Fatigue—Doxorubicin—thyroid cancer	0.000107	0.000307	CcSEcCtD
Pantoprazole—Urticaria—Epirubicin—thyroid cancer	0.000107	0.000306	CcSEcCtD
Pantoprazole—Pain—Doxorubicin—thyroid cancer	0.000106	0.000305	CcSEcCtD
Pantoprazole—Constipation—Doxorubicin—thyroid cancer	0.000106	0.000305	CcSEcCtD
Pantoprazole—Abdominal pain—Epirubicin—thyroid cancer	0.000106	0.000304	CcSEcCtD
Pantoprazole—Body temperature increased—Epirubicin—thyroid cancer	0.000106	0.000304	CcSEcCtD
Pantoprazole—Feeling abnormal—Doxorubicin—thyroid cancer	0.000103	0.000294	CcSEcCtD
Pantoprazole—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000102	0.000291	CcSEcCtD
Pantoprazole—Hypersensitivity—Epirubicin—thyroid cancer	9.91e-05	0.000284	CcSEcCtD
Pantoprazole—Urticaria—Doxorubicin—thyroid cancer	9.89e-05	0.000283	CcSEcCtD
Pantoprazole—Abdominal pain—Doxorubicin—thyroid cancer	9.84e-05	0.000282	CcSEcCtD
Pantoprazole—Body temperature increased—Doxorubicin—thyroid cancer	9.84e-05	0.000282	CcSEcCtD
Pantoprazole—Asthenia—Epirubicin—thyroid cancer	9.65e-05	0.000276	CcSEcCtD
Pantoprazole—Pruritus—Epirubicin—thyroid cancer	9.52e-05	0.000272	CcSEcCtD
Pantoprazole—Diarrhoea—Epirubicin—thyroid cancer	9.21e-05	0.000263	CcSEcCtD
Pantoprazole—Hypersensitivity—Doxorubicin—thyroid cancer	9.17e-05	0.000262	CcSEcCtD
Pantoprazole—Asthenia—Doxorubicin—thyroid cancer	8.93e-05	0.000256	CcSEcCtD
Pantoprazole—Dizziness—Epirubicin—thyroid cancer	8.9e-05	0.000255	CcSEcCtD
Pantoprazole—Pruritus—Doxorubicin—thyroid cancer	8.81e-05	0.000252	CcSEcCtD
Pantoprazole—Vomiting—Epirubicin—thyroid cancer	8.56e-05	0.000245	CcSEcCtD
Pantoprazole—Diarrhoea—Doxorubicin—thyroid cancer	8.52e-05	0.000244	CcSEcCtD
Pantoprazole—Rash—Epirubicin—thyroid cancer	8.48e-05	0.000243	CcSEcCtD
Pantoprazole—Dermatitis—Epirubicin—thyroid cancer	8.48e-05	0.000243	CcSEcCtD
Pantoprazole—Headache—Epirubicin—thyroid cancer	8.43e-05	0.000241	CcSEcCtD
Pantoprazole—Dizziness—Doxorubicin—thyroid cancer	8.23e-05	0.000236	CcSEcCtD
Pantoprazole—Nausea—Epirubicin—thyroid cancer	7.99e-05	0.000229	CcSEcCtD
Pantoprazole—Vomiting—Doxorubicin—thyroid cancer	7.92e-05	0.000227	CcSEcCtD
Pantoprazole—Rash—Doxorubicin—thyroid cancer	7.85e-05	0.000225	CcSEcCtD
Pantoprazole—Dermatitis—Doxorubicin—thyroid cancer	7.84e-05	0.000224	CcSEcCtD
Pantoprazole—Headache—Doxorubicin—thyroid cancer	7.8e-05	0.000223	CcSEcCtD
Pantoprazole—Nausea—Doxorubicin—thyroid cancer	7.4e-05	0.000212	CcSEcCtD
